Your browser doesn't support javascript.
loading
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases.
Li, Zhizhen; Wu, Jianping; Zhou, Ji; Yuan, Baoshi; Chen, Jiqiao; Wu, Wanchen; Mo, Lian; Qu, Zhipeng; Zhou, Fei; Dong, Yingying; Huang, Kai; Liu, Zhiwei; Wang, Tao; Symmes, Deebie; Gu, Jingliang; Sho, Eiketsu; Zhang, Jingping; Chen, Ruihuan; Xu, Ying.
Afiliación
  • Li Z; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Wu J; Laboratory Animal Center, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Zhou J; Luoda Biosciences, Inc., Chuzhou, Anhui, China.
  • Yuan B; Institute of Biology and Medical Sciences, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Chen J; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Wu W; KCI Biotech (Suzhou) Inc., Suzhou, Jiangsu, China.
  • Mo L; Joinn Laboratories (Suzhou), Co., Ltd., Suzhou, Jiangsu, China.
  • Qu Z; Aluda Pharmaceuticals, Inc., Menlo Park, California, USA.
  • Zhou F; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Dong Y; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Huang K; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Liu Z; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Wang T; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Symmes D; Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Su Genomic Resource Center, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Gu J; Aluda Pharmaceuticals, Inc., Menlo Park, California, USA.
  • Sho E; Joinn Laboratories (Suzhou), Co., Ltd., Suzhou, Jiangsu, China.
  • Zhang J; KCI Biotech (Suzhou) Inc., Suzhou, Jiangsu, China.
  • Chen R; Institute of Biology and Medical Sciences, Medical School of Soochow University, Suzhou, Jiangsu, China.
  • Xu Y; Luoda Biosciences, Inc., Chuzhou, Anhui, China.
mBio ; 12(5): e0254221, 2021 10 26.
Article en En | MEDLINE | ID: mdl-34634931
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Compuestos Orgánicos / Vimentina / Glicoproteína de la Espiga del Coronavirus / COVID-19 / Tratamiento Farmacológico de COVID-19 / Antiinflamatorios Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: MBio Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Compuestos Orgánicos / Vimentina / Glicoproteína de la Espiga del Coronavirus / COVID-19 / Tratamiento Farmacológico de COVID-19 / Antiinflamatorios Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: MBio Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos